We are live on
!
Find out more
T
TOBAM Portfolio holdings
AUM
$412M
1-Year Est. Return
18.33%
This Fund
S&P 500
This Quarter
Est. Return
-7.74%
1 Year Est. Return
+18.33%
3 Year Est. Return
+56.05%
5 Year Est. Return
+49%
10 Year Est. Return
+255.15%
AUM
$1.6B
AUM Growth
-$392M
(-20%)
Cap. Flow
-$203M
Cap. Flow
% of AUM
-12.69%
Top 10 Holdings %
Top 10 Hldgs %
25.61%
Holding
503
New
74
Increased
178
Reduced
101
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Quest Diagnostics
DGX
|
+$24.5M |
| 2 |
Church & Dwight Co
CHD
|
+$19.6M |
| 3 |
Eversource Energy
ES
|
+$18.2M |
| 4 |
Expedia Group
EXPE
|
+$17.6M |
| 5 |
Kimberly-Clark
KMB
|
+$17.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$31.2M |
| 2 |
Conagra Brands
CAG
|
+$27M |
| 3 |
SEE
Sealed Air
SEE
|
+$22.8M |
| 4 |
Eli Lilly
LLY
|
+$22.1M |
| 5 |
Regency Centers
REG
|
+$20.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28% |
| 2 | Consumer Staples | 25.89% |
| 3 | Communication Services | 10.3% |
| 4 | Technology | 7.09% |
| 5 | Materials | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Western Union
WU
$2.24B
| $4.02M | 0.25% |
243,811
-185,880
| -43% | -$3.28M |
|
77
Compañía de Minas Buenaventura
BVN
$8.61B
| $3.98M | 0.25% |
603,467
-169,926
| -22% | -$1.47M |
|
78
Alamos Gold
AGI
$15.5B
| $3.89M | 0.24% |
554,906
-48,683
| -8% | -$379K |
|
79
BlackBerry
BB
$4.51B
| $3.83M | 0.24% |
711,301
-434,218
| -38% | -$2.58M |
|
|
HOLX
80
DELISTED
Hologic
HOLX
| $3.61M | 0.23% |
52,056
+50,954
| +4,624% | +$3.78M |
|
|
CTRA
81
DELISTED
Coterra Energy
CTRA
| $3.4M | 0.21% |
132,000
-328,964
| -71% | -$9.98M |
|
|
MASI
82
DELISTED
Masimo
MASI
| $3.4M | 0.21% |
26,013
-31,917
| -55% | -$4.27M |
|
83
Johnson & Johnson
JNJ
$663B
| $3.35M | 0.21% |
18,869
-43
| -0.2% | -$7.66K |
|
|
MRTX
84
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $3.34M | 0.21% |
+49,737
| New | +$3.16M |
|
85
Apple
AAPL
$4.67T
| $3.09M | 0.19% |
22,576
+6,981
| +45% | +$1.06M |
|
86
Akamai
AKAM
$15.1B
| $2.93M | 0.18% |
32,063
-3,399
| -10% | -$354K |
|
87
Vipshop
VIPS
$6.28B
| $2.85M | 0.18% |
287,947
-367,459
| -56% | -$3.24M |
|
88
iQIYI
IQ
$849M
| $2.71M | 0.17% |
645,265
-494,755
| -43% | -$1.99M |
|
89
Netflix
NFLX
$326B
| $2.54M | 0.16% |
145,140
+122,070
| +529% | +$2.71M |
|
90
CMS Energy
CMS
$21.5B
| $2.5M | 0.16% |
37,055
-10,014
| -21% | -$691K |
|
91
UnitedHealth
UNH
$356B
| $2.48M | 0.16% |
4,835
+293
| +6% | +$147K |
|
92
SSR Mining
SSRM
$7.58B
| $2.44M | 0.15% |
146,076
+50,846
| +53% | +$1.05M |
|
93
CVS Health
CVS
$124B
| $2.42M | 0.15% |
26,106
-4,983
| -16% | -$486K |
|
94
Vail Resorts
MTN
$4.81B
| $2.39M | 0.15% |
10,960
-32,939
| -75% | -$8.06M |
|
95
Canadian Imperial Bank of Commerce
CM
$107B
| $2.33M | 0.15% |
48,155
+33,363
| +226% | +$1.82M |
|
96
Peloton Interactive
PTON
$2.37B
| $2.25M | 0.14% |
245,421
-368,312
| -60% | -$5.91M |
|
97
Extra Space Storage
EXR
$29.4B
| $2.16M | 0.14% |
12,675
-93,034
| -88% | -$17.2M |
|
|
ZEN
98
DELISTED
ZENDESK INC
ZEN
| $2.15M | 0.13% |
29,069
+16,340
| +128% | +$1.61M |
|
99
Public Storage
PSA
$55.6B
| $2.06M | 0.13% |
6,585
-13,963
| -68% | -$4.83M |
|
|
SGEN
100
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.02M | 0.13% |
11,413
-30,960
| -73% | -$4.46M |
|
Similar funds
EC
WIP
KP
MP
AWP
THCM
PA
HP
TOBAM's Q2 2022 Portfolio in Review
As of Q2 2022, TOBAM held 503 positions worth $1.6B, down 20% from $1.99B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
TOBAM withdrew a net $203M in Q2 2022, closing 74 positions and reducing 101 holdings. Its most notable exit was Novavax, an estimated $12.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Consumer Staples and Communication Services.
Against the trend, TOBAM opened a new position in Expedia Group worth $11.8M.
- TOBAM's largest Q2 2022 buy was Expedia Group: 124,451 shares worth $11.8M.
- TOBAM added most to Quest Diagnostics in Q2 2022, an estimated $24.5M increase.
- TOBAM's biggest Q2 2022 reduction was Gilead Sciences, cutting an estimated $31.2M.
- TOBAM fully exited Novavax in Q2 2022, selling an estimated $12.8M.
- TOBAM's ten largest holdings make up 26% of its $1.6B portfolio in Q2 2022.
- TOBAM opened 74 new positions and closed 74 in Q2 2022.
- TOBAM's portfolio value fell 20% quarter-over-quarter to $1.6B.
Based on TOBAM's 13F filing for Q2 2022, filed 2 Aug 2022.